investors
Immuneel is championing a momentous change—one that is human, medical, technological and economic. Join us.
A bold initiative to disrupt the landscape of cancer treatment in India, Immuneel is a privately-owned Indian clinical stage startup company established in 2018, and seed-funded through angel investments and institutional capital.
A first mover in India, Immuneel is pioneering the business and care delivery models which will transform the way cell and gene therapies are developed and manufactured while alleviating the suffering of an under-served population.
With an inspired leadership team and a wide sweep of capabilities being built, Immuneel has garnered support from leading investors across hospitals, corporates and institutions on its journey towards scale, reliability and speed.
press releases
Download our latest press release
media
Immuneel story has the attention and interest of the business press and technology writers
Read or watch what the press says about us
Please contact business.communications@immuneel.com for any queries related to media.
Please contact business.communications@immuneel.com for any queries related to media.
